BRIEF-Raptor Pharma says Health Canada accepts NDA for procysbi with priority review status

Mon Mar 21, 2016 4:14pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

March 21 (Reuters) - Raptor Pharmaceutical Corp

* Health canada accepted for review its new drug submission for procysbi delayed-release capsules with priority review status Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)